Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes

Stephanie Krause; Andreas Beyerlein; Christiane Winkler; Anita Gavrisan; Christiane Kayser; Ramona Puff; Ezio Bonifacio; Anette Gabriele Ziegler; Peter Achenbach

doi:10.1007/s00592-013-0512-8

Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes

Stephanie Krause
, Andreas Beyerlein
, Christiane Winkler
, Anita Gavrisan
, Christiane Kayser
, Ramona Puff
, Ezio Bonifacio
, Anette Gabriele Ziegler
, Peter Achenbach

Department of Pediatric Medicine

Helmholtz Zentrum München German Research Center for Environmental Health
Technical University of Munich
Forschergruppe Diabetes e.V.
Technische Universität Dresden
Technischen Universität Dresden

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	517-518
Number of pages	2
Journal	Acta Diabetologica
Volume	51
Issue number	3
DOIs	https://doi.org/10.1007/s00592-013-0512-8
State	Published - Jun 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00592-013-0512-8

Cite this

@article{124afc4c39554c9bae8aa8dbda649e5c,

title = "Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes",

author = "Stephanie Krause and Andreas Beyerlein and Christiane Winkler and Anita Gavrisan and Christiane Kayser and Ramona Puff and Ezio Bonifacio and Ziegler, \{Anette Gabriele\} and Peter Achenbach",

note = "Funding Information: The authors thank A. Knopff, A. Wosch, V. Dietrich, C. Ried, C. Matzke, and M. Scholz for expert technical assistance, and M. Bunk, S. Hummel, M. Krasmann, and A. Huppert for clinical assistance. We also thank all participants of the BABYDIAB, BABYDIET, and Munich family studies. This study was supported in part by grants from the Juvenile Diabetes Research Foundation (JDRF 17-2012-16), and from the German Federal Ministry of Education and Research (BMBF) to the Competence Network for Diabetes mellitus (FKZ 01GI0805). ",

year = "2014",

month = jun,

doi = "10.1007/s00592-013-0512-8",

language = "English",

volume = "51",

pages = "517--518",

journal = "Acta Diabetologica",

issn = "0940-5429",

publisher = "Springer-Verlag Italia s.r.l.",

number = "3",

}

TY - JOUR

T1 - Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes

AU - Krause, Stephanie

AU - Beyerlein, Andreas

AU - Winkler, Christiane

AU - Gavrisan, Anita

AU - Kayser, Christiane

AU - Puff, Ramona

AU - Bonifacio, Ezio

AU - Ziegler, Anette Gabriele

AU - Achenbach, Peter

N1 - Funding Information: The authors thank A. Knopff, A. Wosch, V. Dietrich, C. Ried, C. Matzke, and M. Scholz for expert technical assistance, and M. Bunk, S. Hummel, M. Krasmann, and A. Huppert for clinical assistance. We also thank all participants of the BABYDIAB, BABYDIET, and Munich family studies. This study was supported in part by grants from the Juvenile Diabetes Research Foundation (JDRF 17-2012-16), and from the German Federal Ministry of Education and Research (BMBF) to the Competence Network for Diabetes mellitus (FKZ 01GI0805).

PY - 2014/6

Y1 - 2014/6

UR - https://www.scopus.com/pages/publications/84905257534

U2 - 10.1007/s00592-013-0512-8

DO - 10.1007/s00592-013-0512-8

M3 - Letter

C2 - 24006086

AN - SCOPUS:84905257534

SN - 0940-5429

VL - 51

SP - 517

EP - 518

JO - Acta Diabetologica

JF - Acta Diabetologica

IS - 3

ER -

Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes

UN SDGs

Access to Document

Other files and links

Cite this